The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Research Report 2024
Synopsis
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.
The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at US$ 1645.2 million in 2023 and is anticipated to reach US$ 2205.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
Global key players of enzyme-linked immunosorbent assay (ELISA) include Bio-Rad Laboratorie, Biomerieux, Thermo Fisher Scientific, etc. The top three players hold a share about 24%. Asia-Pacific and North America are the two largest markets, both have a share about 32%, followed by Europe, with share 23%.
This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).
Report Scope
The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enzyme-Linked Immunosorbent Assay (ELISA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
Segment by Type
Indirect ELISA
Sandwich ELISA
Competitive ELISA
Others
Segment by Application
Laboratory
Testing Institutions
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
ELISA Kit (enzyme-linked immunosorbent assay) is the most widely used technology in enzyme immunoassay technology. Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. ELISA kit involve attachment of a capture antibody to a solid phase support. Samples containing known or unknown antigen are then added in a matrix or buffer that will minimize attachment to the solid phase. An enzyme-labeled antibody is then added for detection. Enzyme-linked immunosorbent assay (ELISA) is an analytical, plate-based technique to detect and quantify the presence of an target analyte in a liquid sample using antibodies.
The global Enzyme-Linked Immunosorbent Assay (ELISA) market was valued at US$ 1645.2 million in 2023 and is anticipated to reach US$ 2205.2 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
Global key players of enzyme-linked immunosorbent assay (ELISA) include Bio-Rad Laboratorie, Biomerieux, Thermo Fisher Scientific, etc. The top three players hold a share about 24%. Asia-Pacific and North America are the two largest markets, both have a share about 32%, followed by Europe, with share 23%.
This report aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (ELISA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (ELISA).
Report Scope
The Enzyme-Linked Immunosorbent Assay (ELISA) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enzyme-Linked Immunosorbent Assay (ELISA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
Enzo Life Sciences
BioLegend
Merck
Bio-Techne
BD Biosciences
Bio-Rad Laboratorie
Aviva Systems Biology
Repligen
Lifespan Biosciences
PerkinElmer
BioVision
Innovative Research
Biomatik
Shanghai Kehua Bio-Engineering
Biomerieux
Segment by Type
Indirect ELISA
Sandwich ELISA
Competitive ELISA
Others
Segment by Application
Laboratory
Testing Institutions
Hospital
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enzyme-Linked Immunosorbent Assay (ELISA) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enzyme-Linked Immunosorbent Assay (ELISA) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Overview
1.1 Product Overview and Scope of Enzyme-Linked Immunosorbent Assay (ELISA)
1.2 Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Type
1.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Value Comparison by Type (2024-2030)
1.2.2 Indirect ELISA
1.2.3 Sandwich ELISA
1.2.4 Competitive ELISA
1.2.5 Others
1.3 Enzyme-Linked Immunosorbent Assay (ELISA) Segment by Application
1.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Value by Application: (2024-2030)
1.3.2 Laboratory
1.3.3 Testing Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size Estimates and Forecasts
1.4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue 2019-2030
1.4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales 2019-2030
1.4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Competition by Manufacturers
2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Average Price by Manufacturers (2019-2024)
2.4 Global Enzyme-Linked Immunosorbent Assay (ELISA) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enzyme-Linked Immunosorbent Assay (ELISA), Product Type & Application
2.7 Enzyme-Linked Immunosorbent Assay (ELISA) Market Competitive Situation and Trends
2.7.1 Enzyme-Linked Immunosorbent Assay (ELISA) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enzyme-Linked Immunosorbent Assay (ELISA) Players Market Share by Revenue
2.7.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enzyme-Linked Immunosorbent Assay (ELISA) Retrospective Market Scenario by Region
3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Region: 2019-2030
3.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Region: 2019-2024
3.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Region: 2025-2030
3.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region: 2019-2030
3.3.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region: 2019-2024
3.3.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Region: 2025-2030
3.4 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Facts & Figures by Country
3.4.1 North America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Country (2019-2030)
3.4.3 North America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Facts & Figures by Country
3.5.1 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Country (2019-2030)
3.5.3 Europe Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Facts & Figures by Country
3.6.1 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Country (2019-2030)
3.6.3 Asia Pacific Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Facts & Figures by Country
3.7.1 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Country (2019-2030)
3.7.3 Latin America Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Facts & Figures by Country
3.8.1 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Type (2019-2030)
4.1.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Type (2019-2024)
4.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Type (2025-2030)
4.1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Type (2019-2030)
4.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2019-2030)
4.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2019-2024)
4.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Type (2025-2030)
4.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Type (2019-2030)
4.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Application (2019-2030)
5.1.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Application (2019-2024)
5.1.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales by Application (2025-2030)
5.1.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Sales Market Share by Application (2019-2030)
5.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2019-2030)
5.2.1 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2019-2024)
5.2.2 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue by Application (2025-2030)
5.2.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Revenue Market Share by Application (2019-2030)
5.3 Global Enzyme-Linked Immunosorbent Assay (ELISA) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Corporation Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Thermo Fisher Scientific Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Enzo Life Sciences
6.2.1 Enzo Life Sciences Corporation Information
6.2.2 Enzo Life Sciences Description and Business Overview
6.2.3 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Enzo Life Sciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.2.5 Enzo Life Sciences Recent Developments/Updates
6.3 BioLegend
6.3.1 BioLegend Corporation Information
6.3.2 BioLegend Description and Business Overview
6.3.3 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BioLegend Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.3.5 BioLegend Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Bio-Techne
6.5.1 Bio-Techne Corporation Information
6.5.2 Bio-Techne Description and Business Overview
6.5.3 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Bio-Techne Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.5.5 Bio-Techne Recent Developments/Updates
6.6 BD Biosciences
6.6.1 BD Biosciences Corporation Information
6.6.2 BD Biosciences Description and Business Overview
6.6.3 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BD Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.6.5 BD Biosciences Recent Developments/Updates
6.7 Bio-Rad Laboratorie
6.6.1 Bio-Rad Laboratorie Corporation Information
6.6.2 Bio-Rad Laboratorie Description and Business Overview
6.6.3 Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bio-Rad Laboratorie Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.7.5 Bio-Rad Laboratorie Recent Developments/Updates
6.8 Aviva Systems Biology
6.8.1 Aviva Systems Biology Corporation Information
6.8.2 Aviva Systems Biology Description and Business Overview
6.8.3 Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Aviva Systems Biology Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.8.5 Aviva Systems Biology Recent Developments/Updates
6.9 Repligen
6.9.1 Repligen Corporation Information
6.9.2 Repligen Description and Business Overview
6.9.3 Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Repligen Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.9.5 Repligen Recent Developments/Updates
6.10 Lifespan Biosciences
6.10.1 Lifespan Biosciences Corporation Information
6.10.2 Lifespan Biosciences Description and Business Overview
6.10.3 Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Lifespan Biosciences Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.10.5 Lifespan Biosciences Recent Developments/Updates
6.11 PerkinElmer
6.11.1 PerkinElmer Corporation Information
6.11.2 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Description and Business Overview
6.11.3 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.11.4 PerkinElmer Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.11.5 PerkinElmer Recent Developments/Updates
6.12 BioVision
6.12.1 BioVision Corporation Information
6.12.2 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Description and Business Overview
6.12.3 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BioVision Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.12.5 BioVision Recent Developments/Updates
6.13 Innovative Research
6.13.1 Innovative Research Corporation Information
6.13.2 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Description and Business Overview
6.13.3 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Innovative Research Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.13.5 Innovative Research Recent Developments/Updates
6.14 Biomatik
6.14.1 Biomatik Corporation Information
6.14.2 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Description and Business Overview
6.14.3 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Biomatik Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.14.5 Biomatik Recent Developments/Updates
6.15 Shanghai Kehua Bio-Engineering
6.15.1 Shanghai Kehua Bio-Engineering Corporation Information
6.15.2 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Description and Business Overview
6.15.3 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shanghai Kehua Bio-Engineering Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.15.5 Shanghai Kehua Bio-Engineering Recent Developments/Updates
6.16 Biomerieux
6.16.1 Biomerieux Corporation Information
6.16.2 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Description and Business Overview
6.16.3 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Biomerieux Enzyme-Linked Immunosorbent Assay (ELISA) Product Portfolio
6.16.5 Biomerieux Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Chain Analysis
7.2 Enzyme-Linked Immunosorbent Assay (ELISA) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enzyme-Linked Immunosorbent Assay (ELISA) Production Mode & Process
7.4 Enzyme-Linked Immunosorbent Assay (ELISA) Sales and Marketing
7.4.1 Enzyme-Linked Immunosorbent Assay (ELISA) Sales Channels
7.4.2 Enzyme-Linked Immunosorbent Assay (ELISA) Distributors
7.5 Enzyme-Linked Immunosorbent Assay (ELISA) Customers
8 Enzyme-Linked Immunosorbent Assay (ELISA) Market Dynamics
8.1 Enzyme-Linked Immunosorbent Assay (ELISA) Industry Trends
8.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Drivers
8.3 Enzyme-Linked Immunosorbent Assay (ELISA) Market Challenges
8.4 Enzyme-Linked Immunosorbent Assay (ELISA) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
